Parés A - Search Results

1

Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis.

Lozano F, Parés A, Borche L, Plana M, Gallart T, Rodés J, Vives J. Lozano F, et al. Among authors: pares a. Hepatology. 1988 Jul-Aug;8(4):930-8. doi: 10.1002/hep.1840080438. Hepatology. 1988. PMID: 3292364

2

[Epidemiology of primary biliary cirrhosis in Cataluna].

Parés A, Bruguera M, Rodés J, Villagrasa M, Guardia J, Serés I, Vilardell F. Parés A, et al. Med Clin (Barc). 1984 Feb 18;82(6):237-41. Med Clin (Barc). 1984. PMID: 6708644 Spanish. No abstract available.

3

[Is primary biliary cirrhosis a generalized disease of autoimmune type?].

Rodés J, Parés A, Bruguera M. Rodés J, et al. Among authors: pares a. Med Clin (Barc). 1987 Feb 21;88(7):292-9. Med Clin (Barc). 1987. PMID: 3561076 Spanish. No abstract available.

4

[Primary biliary cirrhosis, a multisystemic disease?].

Rodés J, Parés A. Rodés J, et al. Among authors: pares a. Med Clin (Barc). 1986 Sep 13;87(7):285-7. Med Clin (Barc). 1986. PMID: 3489869 Spanish. No abstract available.

5

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V; RELIEF study group. Bañares R, et al. Among authors: pares a. Hepatology. 2013 Mar;57(3):1153-62. doi: 10.1002/hep.26185. Epub 2013 Feb 15. Hepatology. 2013. PMID: 23213075 Clinical Trial.

6

Management of osteoporosis in liver disease.

Guañabens N, Parés A. Guañabens N, et al. Among authors: pares a. Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):438-45. doi: 10.1016/j.clinre.2011.03.007. Epub 2011 May 4. Clin Res Hepatol Gastroenterol. 2011. PMID: 21546334 Review.

7

Treatment of bone disorders in liver disease.

Parés A, Guañabens N. Parés A, et al. J Hepatol. 2006 Sep;45(3):445-53. doi: 10.1016/j.jhep.2006.06.007. Epub 2006 Jul 7. J Hepatol. 2006. PMID: 16844255 Review. No abstract available.

8

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.

Parés A, Caballería L, Rodés J. Parés A, et al. Gastroenterology. 2006 Mar;130(3):715-20. doi: 10.1053/j.gastro.2005.12.029. Gastroenterology. 2006. PMID: 16530513

9

Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.

Parés A, Herrera M, Avilés J, Sanz M, Mas A. Parés A, et al. J Hepatol. 2010 Aug;53(2):307-12. doi: 10.1016/j.jhep.2010.02.031. Epub 2010 May 7. J Hepatol. 2010. PMID: 20580987

10

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.

Guañabens N, Parés A, Ros I, Caballería L, Pons F, Vidal S, Monegal A, Peris P, Rodés J. Guañabens N, et al. Among authors: pares a. J Hepatol. 2005 Apr;42(4):573-7. doi: 10.1016/j.jhep.2004.11.035. Epub 2005 Jan 13. J Hepatol. 2005. PMID: 15763344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results